Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07316725

the Effect of Virtual Reality Exercise on Selected Electrolytes Levels in Intradialytic Patients

this study will be conducted to investigate the effect of Intra-Dialysis virtual reality exercise on selected electrolytes balance in patients with end stage renal disease.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

Chronic Kidney Disease (CKD) is a progressive condition that often leads to end-stage renal disease, requiring dialysis. Patients undergoing hemodialysis frequently experience physical inactivity and electrolyte imbalances, which can adversely affect their health outcomes. Regular physical activity is crucial for maintaining muscle strength and physical function in CKD patients.Electrolytes play vital roles in various physiological functions, including muscle contraction, nerve transmission, and fluid balance. In end stage renal disease patients, imbalances can lead to serious complications, including: hyperkalemia, Hyponatremia, and hypocalcemia.VR has been employed in medicine to assist patients in recovering their motor and cognitive abilities. It has proven effective in enhancing physical functions such as posture, balance, and motor skills. When combined with physical exercise, VR has been shown to improve the functional abilities and quality of life of hemodialysis patients. For those with end stage renal disease patients, who experience discomfort during hemodialysis, VR offers a distraction that can reduce the perception of pain, fatigue, nausea, lightheadedness, and headaches, thereby facilitating smoother exercise continuity and enhancing overall adherence to rehabilitation activities. so this study will be conducted to assess the effect of Intra-Dialysis Virtual Reality Exercise on Selected Electrolytes Balance in Patients with End Stage Renal Disease

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients are diagnosed with end stage renal disease on regular dialysis.
  • Their ages will be arranged from 20-40 years old.
  • All patients are under medical control.
  • Patients on regular dialysis more than 3 months.

Exclusion criteria

  • Visual impairment.
  • Severe cognitive impairment.
  • Recent major surgery.
  • Patients with sever musculoskeletal problems.
  • Severe cardiovascular disease limiting exercise.
  • Patients with Hemoglobin drop less than 9 g/dl

Treatment and study plan

Virtual Reality Exercise

Other

the patients will receive 30 minutes virtual reality exercise; (5 minutes warm Up stretching exercise - 20 minutes cycling exercise -5 minutes cool down stretching exercise) plus standard care

Standard care

Other

the patients will receive standard care in the form of medical care

Primary outcomes

  1. Serum Electrolyte Levels

    Time frame: up to three months

    Measurements the level of sodium, potassium, calcium and phosphorus by venous blood sample. the normal value for Sodium: 135-145 mEq/L

    ,Potassium: 3.5-5.0 mEq/L, Calcium: 8.5-10.2 mg/dL, and Phosphorus: 2.5-4.5 mg/dL

Secondary outcomes

  1. blood pressure

    Time frame: up to three months

    A sphygmomanometer will be used to assess blood pressure with normal range 120/80

  2. oxygen saturation levels

    Time frame: up to three months

    A pulse oximeter will be used to assess oxygen saturation level. 95-100% considered normal for healthy individuals

  3. functional exercise capacity

    Time frame: up to three months

    6-Minute Walk Test will be used to assess functional exercises capacity

  4. exercise intensity

    Time frame: up to three months

    The Rated Perceived Exertion (RPE) Scale will be used to assess exercise intensity. it is a subjective 6-20 scale measuring exercise intensity, where 6 is no effort (rest) and 20 is maximum effort.

Study contacts

Contact information is provided by the study sponsor or research team.

sarah mohamed, master

CONTACT

[email protected]

01149967455

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Acronym: VRE

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jan 5, 2026
Registry last updated
Jan 5, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.